Iomai Corporation
Iomai Corporation discovers and develops vaccines and immune system stimulants, delivered via a novel, needle-free technology called.
Launch date
Employees
Market cap
-
Enterprise valuation
$216—324m (Dealroom.co estimates Jan 2003.)
Gaithersburg Maryland (HQ)
Authorizing premium user...